<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> has a well-recognized association with <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, around half of which have been <z:hpo ids='HP_0011009'>acute</z:hpo> myelogenous <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>There are also numerous reports of <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> in association with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report two patients with <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> in whom the classical histological appearances were preceded by dermal lymphocytic infiltrates </plain></SENT>
<SENT sid="3" pm="."><plain>A literature search using PubMed indicates that this phenomenon has not been previously reported </plain></SENT>
<SENT sid="4" pm="."><plain>The cases demonstrate the chronicity of Sweet's lesions in association with haematological disease and the need for repeat biopsies to make the diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>We also describe successful treatment with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, which adds to the list of second-line drugs that may be used in <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> </plain></SENT>
</text></document>